The global digestive health market was valued at $38,789.13 million in 2021, and is projected to reach $90,205.67 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.
Digestive health is one of the main concerns that everyone talks about every day. The overall health of a person can be greatly impacted by an unhealthy gut and thus, to avoid the same, the body needs nutrients to ensure normal digestive function and to maximize the benefits from their diet, which includes a wide range of products from probiotics to digestive enzymes. These promote healthy body function and assist in management of pathogenic microbes from the mouth to stomach. In addition, probiotics supplements assist in digestion process and enhance nutrient absorption when used in proper amount.
According to the National Center for Biotechnology Information (NCBI), gastrointestinal diseases affect an estimated 60 to 70 million people annually in America, with colorectal cancer as the 2nd leading cancer type diagnosed among American men and women. Thus, there is a growing prevalence of digestive diseases around the globe, which further propels the need for digestive health products.
Furthermore, growth of the digestive health market is anticipated to be facilitated by introduction of numerous advancements in products by the pharmaceutical and nutraceutical companies, increase in demand for solutions to treat chronic digestive diseases, and availability of wide range of products and supplements that are easily accessible and cost-effective.
Moreover, with growth in trend of "Gut Health-Key of Weight Management, " prebiotics manufacturers are scrambling to keep up with the rising demand for prebiotics globally. Researchers discovered that the bacteria in the gut, which aid in digestion and absorption of nutrients in intestines, can affect capacity to lose weight, thus leading to rise in demand for prebiotics among weight conscious population and propelling the market growth.
Rse in digestive issues among individuals, owing to lack of sports and fitness activities, growing focus of the population on healthy nutrition, and rise in investments by consumers in probiotics for digestive health and rising preference for functional foods, along with new product launches, propel the market growth. Whereas, increase in R&D initiatives by key market players provide lucrative opportunities for growth of the market.
Although, there are various factors that propel the market growth, there are few restraints that affect the market including stringent government regulations and high development cost associated with the manufacturing process. For instance, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act) requires dietary supplement companies to register with FDA and provide FDA with sufficient information to contact companies in an emergency.
The digestive health market is segmented on the basis of product, form, distribution channel, and region. By product, it is divided into prebiotics, probiotics, and digestive enzymes. On the basis of type, it is segmented into capsules, tablets, and others. By distribution channel, it is segmented into drug stores & retail pharmacies, online providers, and others (supermarkets/hypermarkets). The drug stores & retail pharmacies segment is further divided into prescription and OTC (over-the-counter). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include Amway Corporation, Bayer AG, BASF SE, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Nestle SA, NOW Health Group Inc., Pfizer Inc., Sanofi, and the Bountiful Company (Nature’s Bounty).
Digestive health is one of the main concerns that everyone talks about every day. The overall health of a person can be greatly impacted by an unhealthy gut and thus, to avoid the same, the body needs nutrients to ensure normal digestive function and to maximize the benefits from their diet, which includes a wide range of products from probiotics to digestive enzymes. These promote healthy body function and assist in management of pathogenic microbes from the mouth to stomach. In addition, probiotics supplements assist in digestion process and enhance nutrient absorption when used in proper amount.
According to the National Center for Biotechnology Information (NCBI), gastrointestinal diseases affect an estimated 60 to 70 million people annually in America, with colorectal cancer as the 2nd leading cancer type diagnosed among American men and women. Thus, there is a growing prevalence of digestive diseases around the globe, which further propels the need for digestive health products.
Furthermore, growth of the digestive health market is anticipated to be facilitated by introduction of numerous advancements in products by the pharmaceutical and nutraceutical companies, increase in demand for solutions to treat chronic digestive diseases, and availability of wide range of products and supplements that are easily accessible and cost-effective.
Moreover, with growth in trend of "Gut Health-Key of Weight Management, " prebiotics manufacturers are scrambling to keep up with the rising demand for prebiotics globally. Researchers discovered that the bacteria in the gut, which aid in digestion and absorption of nutrients in intestines, can affect capacity to lose weight, thus leading to rise in demand for prebiotics among weight conscious population and propelling the market growth.
Rse in digestive issues among individuals, owing to lack of sports and fitness activities, growing focus of the population on healthy nutrition, and rise in investments by consumers in probiotics for digestive health and rising preference for functional foods, along with new product launches, propel the market growth. Whereas, increase in R&D initiatives by key market players provide lucrative opportunities for growth of the market.
Although, there are various factors that propel the market growth, there are few restraints that affect the market including stringent government regulations and high development cost associated with the manufacturing process. For instance, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act) requires dietary supplement companies to register with FDA and provide FDA with sufficient information to contact companies in an emergency.
The digestive health market is segmented on the basis of product, form, distribution channel, and region. By product, it is divided into prebiotics, probiotics, and digestive enzymes. On the basis of type, it is segmented into capsules, tablets, and others. By distribution channel, it is segmented into drug stores & retail pharmacies, online providers, and others (supermarkets/hypermarkets). The drug stores & retail pharmacies segment is further divided into prescription and OTC (over-the-counter). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include Amway Corporation, Bayer AG, BASF SE, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Nestle SA, NOW Health Group Inc., Pfizer Inc., Sanofi, and the Bountiful Company (Nature’s Bounty).
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive health market analysis from 2021 to 2031 to identify the prevailing digestive health market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the digestive health market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global digestive health market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Prebiotics
- Probiotics
- Digestive Enzymes
By Form
- Capsule
- Tablet
- Others
By Distribution Channel
- Drug Stores and Retail Pharmacies
- Type
- Prescription
- OTC
- Online Providers
- Others
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- Bayer AG
- GalaxoSmithKline PLC
- Pfizer Inc.
- Sanofi
- Nestle SA
- Herbalife Nutrition Ltd.
- BASF SE
- NOW Health Group Inc.
- Amway Corporation
- The Bountiful Company (Nature’s Bounty)
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
3.7. Patent Landscape
CHAPTER 4: DIGESTIVE HEALTH MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Prebiotics
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Probiotics
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Digestive Enzymes
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: DIGESTIVE HEALTH MARKET, BY FORM
5.1 Overview
5.1.1 Market size and forecast
5.2 Capsule
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Tablet
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Drug Stores and Retail Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.2.4 Drug Stores and Retail Pharmacies Digestive Health Market by Type
6.2.4.1 Prescription Market size and forecast, by region
6.2.4.2 OTC Market size and forecast, by region
6.3 Online Providers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: DIGESTIVE HEALTH MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Form
7.2.4 North America Market size and forecast, by Distribution Channel
7.2.4.1 North America Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Form
7.2.5.1.3 Market size and forecast, by Distribution Channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Form
7.2.5.2.3 Market size and forecast, by Distribution Channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Form
7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Form
7.3.4 Europe Market size and forecast, by Distribution Channel
7.3.4.1 Europe Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Form
7.3.5.1.3 Market size and forecast, by Distribution Channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Form
7.3.5.2.3 Market size and forecast, by Distribution Channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Form
7.3.5.3.3 Market size and forecast, by Distribution Channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Form
7.3.5.4.3 Market size and forecast, by Distribution Channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Form
7.3.5.5.3 Market size and forecast, by Distribution Channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Form
7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Form
7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
7.4.4.1 Asia-Pacific Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Form
7.4.5.1.3 Market size and forecast, by Distribution Channel
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Form
7.4.5.2.3 Market size and forecast, by Distribution Channel
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Form
7.4.5.3.3 Market size and forecast, by Distribution Channel
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Form
7.4.5.4.3 Market size and forecast, by Distribution Channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Form
7.4.5.5.3 Market size and forecast, by Distribution Channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Form
7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Form
7.5.4 LAMEA Market size and forecast, by Distribution Channel
7.5.4.1 LAMEA Drug Stores and Retail Pharmacies Digestive Health Market by Type
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Form
7.5.5.1.3 Market size and forecast, by Distribution Channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Form
7.5.5.2.3 Market size and forecast, by Distribution Channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Form
7.5.5.3.3 Market size and forecast, by Distribution Channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Form
7.5.5.4.3 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Bayer AG
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 GalaxoSmithKline PLC
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Pfizer Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Sanofi
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Nestle SA
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Herbalife Nutrition Ltd.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 BASF SE
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 NOW Health Group Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Amway Corporation
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 The Bountiful Company (Nature’s Bounty)
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Digestive Health Market,' the digestive health market size was valued at $38.8 billion in 2021, and is estimated to reach $90.2 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031.Digestive health products aim to strengthen the human immune system, by enhancing activities of the digestive system. Presence of several enzymes in digestive health products, such as lipases, amylases, and lactases aid in maintaining stomach acid levels and enhancing nutritional digestion. In addition, products and supplements manufactured by key market players are also responsible to maintain the digestive health.
Moreover, in western democracies, probiotics, which are essential to sustaining a healthy gut micro biota are becoming more and more popular among consumers that follow a holistic approach to healthy living. Thus, it is projected that during the forecast period, demand for digestive health products would rise as consumer knowledge of gut health increases. In addition, the U.S. is anticipated to continue to have a large increase in demand for digestive health, owing to poor eating practices and high consumption of processed, high-sodium, and ready-to-eat meals, prevalence of obesity, digestive disorders, and lifestyle-related diseases.
Furthermore, according to the World Health Organization, 39 million children under the age of 5 were overweight or obese in 2020, and worldwide obesity nearly tripled since 1975. As digestive health plays an important role in weight management, a greater number of obese population are turning toward digestive health management for weight loss process, thus propelling the growth of the digestive health market trends.
However, before launching the products, manufacturers need to apply for the large number of certifications and testing which includes a huge amount of investment for the approval of the product. Furthermore, the company's material development costs limit its ability to grow, which provides hindrance to the digestive health market growth.
According to the type, probiotics segment was the largest segment in the 2021, owing to increase in understanding of advantages that probiotics have for health, including prevention of irritable bowel syndrome, treatment and prevention of diarrhea, reduction of allergens and inflammation, and enhancement of immunity and the digestive enzymes segment is expected to grow at a highest CAGR during the forecast period.
By form, the capsules segment held a dominant portion in the global digestive health market in 2021. This is mainly attributed to increase in demand for digestive health solutions, owing to increase in number of cases associated with gastrointestinal disorders, and awareness about usage of the of capsule dosage form, and is also expected to grow at the fastest rate of CAGR during the forecast period.
By distribution channel, the drug stores and retail pharmacies owned the largest digestive health market share of the market in 2021, owing to rise in adoption for digestive supplements by large population from the preference for preventative medicine along with development of effective probiotic strains for dairy products to reduce intestinal inflammation, enhance gut health, and boost immunity. On the other hand, the online providers are expected to grow at the highest CAGR during the forecast period.
Region wise, North America acquired a major digestive health industry share in the year 2021, owning to meet the requirements of costumers, manufacturers of digestive health solutions and key players concentrating on creating innovative and effective products. However, Asia-Pacific is expected to witness highest growth at a CAGR for the digestive health products industry during the forecast period, owing to investments by public and private market players in this field.
According to Onkar Sumant, Manager, Healthcare,'Rise in the geriatric population, increasing healthcare costs, changing lifestyle of developed and developing nations, and innovation in solutions of digestive health products are primary factors that have contributed towards market growth.'
KEY FINDINGS OF THE STUDY
By type, the probiotics segment was the highest contributor to the market in 2021.By form, the capsules segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.
Depending on distribution channel, the drug store & retail pharmacies segment was highest contributor in 2021.
Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Bayer AG
- Galaxosmithkline PLC
- Pfizer Inc.
- Sanofi
- Nestle SA
- Herbalife Nutrition Ltd.
- BASF SE
- Now Health Group Inc.
- Amway Corporation
- the Bountiful Company (Nature's Bounty)
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 310 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 38789.13 million |
| Forecasted Market Value ( USD | $ 90205.67 million |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
